Hypoxia inducible factor-1 mediates expression of galectin-1: The potential role in migration/invasion of colorectal cancer cells

Carcinogenesis

Volumn 31, Issue 8, 2010, Pages 1367-1375

  Zhao, Xu Yun ^a   Chen, Ting Ting ^a   Xia, Li ^a   Guo, Meng ^a   Xu, Ying ^a   Yue, Fei ^a   Jiang, Yi ^a   Chen, Guo Qiang ^a   Zhao, Ke Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 1; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; SHORT HAIRPIN RNA; SUMO 1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DNA PRIMERS; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; LUCIFERASES; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 77955387572     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq116     Document Type: Article

References (44)

1. Harris,A.L. (2002) Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer, 2, 38-47.
2. Vaupel,P. (2008) Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist, 13 (suppl. 3), 21-26.
3. Wang,G.L. et al. (1995) Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA, 92, 5510-5514.
4. Semenza,G.L. (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE, 2007, cm8.
5. Jaakkola,P. et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-472.
6. Huang,Y. et al. (2003) Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha. Leukemia, 17, 2065-2073.
7. Song,L.P. et al. (2008) Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Oncogene, 27, 519-527.
8. Wenger,R.H. et al. (2005) Integration of oxygen signaling at the consensus HRE. Sci. STKE, 2005, re12.
9. Liao,S.H. et al. (2009) Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells. Proteomics, 9, 3901-3912.
10. Isaacs,J.S. et al. (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell, 8, 143-153.
11. Kim,W.Y. et al. (2004) Role of VHL gene mutation in human cancer. J. Clin. Oncol., 22, 4991-5004.
12. Khandrika,L. et al. (2009) Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF1alpha levels contribute to emergence of an aggressive phenotype in prostate cancer. Oncogene, 28, 1248-1260.
13. Fan,L.F. et al. (2008) Role of Hypoxia-inducible factor-1 alpha and Survivin in colorectal carcinoma progression. Int. J. Colorectal Dis., 23, 1057-1064.
14. Hsieh,S.H. et al. (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene, 27, 3746-3753.
15. Funasaka,T. et al. (2005) Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. Faseb J., 19, 1422-1430.
16. Barondes,S.H. et al. (1994) Galectins: a family of animal beta-galactosidebinding lectins. Cell, 76, 597-598.
17. Liu,F.T. et al. (2005) Galectins as modulators of tumour progression. Nat. Rev. Cancer, 5, 29-41.
18. Wincewicz,A. et al. (2007) Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer. Ann. N. Y. Acad. Sci., 1095, 53-61.
19. Demydenko,D. et al. (2009) Expression of galectin-1 in malignant tumors. Exp. Oncol., 31, 74-79.
20. Semenza,G.L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer, 3, 721-732.
21. Cheng,J. et al. (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell, 131, 584-595.
22. Elson,D.A. et al. (2000) Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res., 60, 6189-6195.
23. Rankin,E.B. et al. (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ., 15, 678-685.
24. Krishnamachary,B. et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res., 63, 1138-1143.
25. Krishnamachary,B. et al. (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res., 66, 2725-2731.
26. Case,D. et al. (2007) Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol., 292, L154-L164.
27. Le,Q.T. et al. (2005) Galectin-1: a link between tumor hypoxia and tumor immune privilege. J. Clin. Oncol., 23, 8932-8941.
28. Le Mercier,M. et al. (2008) Evidence of galectin-1 involvement in glioma chemoresistance. Toxicol. Appl. Pharmacol., 229, 172-183.
29. Le,Q.T. et al. (2007) Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Int. J. Radiat. Oncol. Biol. Phys., 69, 167-175.
30. Hittelet,A. et al. (2003) Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int. J. Cancer, 103, 370-379.
31. Nagy,N. et al. (2003) Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer, 97, 1849-1858.
32. Dang,C.V. et al. (2008) The interplay between MYC and HIF in cancer. Nat. Rev. Cancer, 8, 51-56.
33. Yang,L. et al. (2008) CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis, 29, 291-298.
34. Yoo,Y.G. et al. (2009) An essential role of the HIF-1alpha-c-Myc axis in malignant progression. Ann. N. Y. Acad. Sci., 1177, 198-204.
35. Peng,Z.G. et al. (2008) Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha. Oncogene, vol. 27, 839-847.
36. Yang,R.Y. et al. (2008) Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med., 10, e17.
37. Camby,I. et al. (2006) Galectin-1: a small protein with major functions. Glycobiology, 16, 137R-157R.
38. Thijssen,V.L. et al. (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl Acad. Sci. USA, 103, 15975-15980.
39. Elola,M.T. et al. (2007) Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell. Mol. Life Sci., 64, 1679-1700.
40. Georgiadis,V. et al. (2007) Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration. Dev. Dyn., 236, 1014-1024.
41. Jung,E.J. et al. (2007) Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int. J. Cancer, 120, 2331-2338.
42. Wu,M.H. et al. (2009) Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol. Cancer Res., 7, 311-318.
43. Ohannesian,D.W. et al. (1994) Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res., 54, 5992-6000.
44. Imamura,T. et al. (2009) HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int. J. Cancer, 124, 763-771.